682 results on '"Adelstein, David J."'
Search Results
202. Developing an In-Training Examination for Fellows: The Experience of the American Society of Clinical Oncology
203. Extent of neck dissection required after concurrent chemoradiation for stage IV head and neck squamous cell carcinoma
204. Utility of Positron Emission Tomography Compared With Mediastinoscopy for Delineating Involved Lymph Nodes in Stage III Lung Cancer: Insights for Radiotherapy Planning From a Surgical Cohort
205. Redefining the Role of Induction Chemotherapy in Head and Neck Cancer
206. Current and Emerging Standards of Concomitant Chemoradiotherapy
207. Concurrent Chemoradiotherapy in the Management of Squamous Cell Cancer of the Oropharynx: Current Standards and Future Directions
208. A Phase II Trial of Accelerated Multimodality Therapy for Locoregionally Advanced Cancer of the Esophagus and Gastroesophageal Junction
209. Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer–only brain metastases
210. Brain Metastases From Esophageal Cancer: A Phenomenon of Adjuvant Therapy?
211. Risk factors for hypopharyngeal/upper esophageal stricture formation after concurrent chemoradiation
212. Systemic chemotherapy for squamous cell head and neck cancer
213. In Reply
214. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer?
215. Factors Associated with Improved Survival in Patients with Brain Metastases from Esophageal Cancer: A Retrospective Review
216. Patterns of Local Failure after Esophagectomy for Invasive Esophageal Carcinoma
217. Author reply
218. Strategies for Protecting Normal Tissue in the Treatment of Head and Neck Cancer.
219. Chemoprevention in Head and Neck Cancer.
220. Palliation of Head and Neck Cancer.
221. Quality of Life Outcomes in Head and Neck Cancer.
222. Gene Therapy for Patients With Head and Neck Cancer.
223. Postoperative Treatment of Locally Advanced Head and Neck Cancers.
224. Targeted Therapies in Head and Neck Cancer.
225. T3-T4 Squamous Cell Carcinoma of the Larynx Treated With Radiation Therapy Alone or Combined With Adjuvant Chemotherapy.
226. Multimodality Management of Nasopharyngeal Carcinoma.
227. Concurrent Chemoradiotherapy.
228. The Evolution of Induction Chemotherapy in Locally Advanced Squamous Cell Cancer of the Head and Neck.
229. Induction Chemotherapy in Head and Neck Cancer.
230. The Role of Tumor Hypoxia in Head and Neck Cancer Radiotherapy.
231. Altered Fractionation.
232. Intensity-Modulated Radiation Therapy in the Management of Head and Neck Cancer.
233. Role of Brachytherapy in Treatment of Head and Neck Malignancy.
234. Salvage Surgery After Chemoradiation Therapy.
235. Laryngeal Preservation Surgery.
236. The Evolving Role of Neck Dissection in the Era of Organ Preservation Therapy for Head and Neck Squamous Cell Carcinoma.
237. Laser Surgery for Head and Neck Cancer.
238. Head and Neck Squamous Cell Cancers in the Nonsmoker-Nondrinker.
239. Superficial adenocarcinoma of the esophagus
240. P53 and Ki‐67 as Outcome Predictors for Advanced Squamous Cell Cancers of the Head and Neck Treated With Chemoradiotherapy
241. Enteral nutrition during the treatment of head and neck carcinoma
242. Esophageal carcinoma: Importance and associations of N1 burden
243. Preoperative Chemoradiotherapy Using Taxanes for Locally Advanced Esophageal Carcinoma
244. N1 esophageal carcinoma: The importance of staging and downstaging
245. Hypothyroidism
246. Oncologic and Functional Outcomes of Surgical and Nonsurgical Treatment of Advanced Squamous Cell Carcinoma of the Supraglottic Larynx
247. Does Paclitaxel Improve the Chemoradiotherapy of Locoregionally Advanced Esophageal Cancer? A Nonrandomized Comparison With Fluorouracil-Based Therapy
248. Adrenal Mass Evaluation in Patients with Lung Carcinoma
249. Mature results of a Phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with Stage III and IV squamous cell carcinoma of the head and neck
250. A Phase II Trial of Induction Epirubicin, Oxaliplatin, and Fluorouracil, Followed by Surgery and Postoperative Concurrent Cisplatin and Fluorouracil Chemoradiotherapy in Patients with Locoregionally Advanced Adenocarcinoma of the Esophagus and Gastroesophageal Junction.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.